IL-15 抗体
(Interleukin 15 (IL15))
The protein encoded by this gene is a cytokine that regulates T and natural killer cell activation and proliferation. This cytokine and interleukine 2 share many biological activities. They are found to bind common hematopoietin receptor subunits, and may compete for the same receptor, and thus negatively regulate each other's activity. The number of CD8+ memory cells is shown to be controlled by a balance between this cytokine and IL2. This cytokine induces the activation of JAK kinases, as well as the phosphorylation and activation of transcription activators STAT3, STAT5, and STAT6. Studies of the mouse counterpart suggested that this cytokine may increase the expression of apoptosis inhibitor BCL2L1/BCL-x(L), possibly through the transcription activation activity of STAT6, and thus prevent apoptosis. Alternatively spliced transcript variants of this gene have been reported. [provided by RefSeq, Feb 2011].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| Recombinant IL-15 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| IL-15 抗体 (C-Term) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| Recombinant IL-15 抗体 | 人, 大鼠, 小鼠 | 兔 Monoclonal |
|
|
|
| IL-15 抗体 (AA 70-162) | 人, 大鼠 | 兔 Polyclonal |
|
|
|
| IL-15 抗体 | Cow | 小鼠 Monoclonal |
|
|
|
| IL-15 抗体 | 小鸡 | 兔 Polyclonal |
|
|
|
| IL-15 抗体 | Pig | 兔 Polyclonal |
|
|
|
| IL-15 抗体 (AA 111-160) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| IL-15 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| IL-15 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| IL-15 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| IL-15 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| IL-15 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| IL-15 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| Recombinant IL-15 抗体 (AA 1-152) | 人 | 小鼠 Monoclonal |
|
|
|
| IL-15 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| Recombinant IL-15 抗体 (AA 1-152) | 人 | 小鼠 Monoclonal |
|
|
|
| Recombinant IL-15 抗体 (AA 1-152) | 人 | 小鼠 Monoclonal |
|
|
|
| Recombinant IL-15 抗体 (AA 1-152) | 人 | 小鼠 Monoclonal |
|
|
|
| IL-15 抗体 | 人 | 小鼠 Monoclonal |
|
|
Primary Antibody
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 12B11E5
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG1
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
Primary Antibody
- ELISA (ELISA: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 70-162
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 111-160
Primary Antibody
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 质量等级
- Carrier-free
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- rIL15-8049
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG1, kappa
- 抗原表位
- AA 1-152
Primary Antibody
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 质量等级
- Carrier-free
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- rIL15-8050
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG1, kappa
- 抗原表位
- AA 1-152
Primary Antibody
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- rIL15-8050
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG1, kappa
- 抗原表位
- AA 1-152
Primary Antibody
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- rIL15-8049
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG1, kappa
- 抗原表位
- AA 1-152
Latest Publications for our IL-15 抗体
: "Impaired TGF-β signaling in patients with active systemic lupus erythematosus is associated with an overexpression of IL-22." in: Cytokine, Vol. 108, pp. 182-189, (2018) (PubMed).
: ""Inflamm-aging" influences immune cell survival factors in human bone marrow." in: European journal of immunology, Vol. 47, Issue 3, pp. 481-492, (2017) (PubMed).
: "Dendritic Cell-Derived IL-32α: A Novel Inhibitory Cytokine of NK Cell Function." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 199, Issue 4, pp. 1290-1300, (2017) (PubMed).
: "A Refractory Celiac Patient Successfully Treated With Mesenchymal Stem Cell Infusions." in: Mayo Clinic proceedings, Vol. 91, Issue 6, pp. 812-9, (2016) (PubMed).
: "Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner." in: PLoS ONE, Vol. 10, Issue 5, pp. e0123340, (2015) (PubMed).
: "IL15RA drives antagonistic mechanisms of cancer development and immune control in lymphocyte-enriched triple-negative breast cancers." in: Cancer research, Vol. 74, Issue 17, pp. 4908-21, (2014) (PubMed).
: "CD8+ T cells are activated in an antigen-independent manner in HIV-infected individuals." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 192, Issue 4, pp. 1732-44, (2014) (PubMed).
: "Interleukin-15 enhances cellular proliferation and upregulates CNS homing molecules in pre-B acute lymphoblastic leukemia." in: Blood, Vol. 123, Issue 20, pp. 3116-27, (2014) (PubMed).
: "Qualitatively different T cell phenotypic responses to IL-2 versus IL-15 are unified by identical dependences on receptor signal strength and duration." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 192, Issue 1, pp. 123-35, (2013) (PubMed).
: "Phenotypic and functional characterization of NK cells in human immune response against the dimorphic fungus Paracoccidioides brasiliensis." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 189, Issue 2, pp. 935-45, (2012) (PubMed).
: ""Inflamm-aging" influences immune cell survival factors in human bone marrow." in: European journal of immunology, Vol. 47, Issue 3, pp. 481-492, (2017) (PubMed).
: "Dendritic Cell-Derived IL-32α: A Novel Inhibitory Cytokine of NK Cell Function." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 199, Issue 4, pp. 1290-1300, (2017) (PubMed).
: "A Refractory Celiac Patient Successfully Treated With Mesenchymal Stem Cell Infusions." in: Mayo Clinic proceedings, Vol. 91, Issue 6, pp. 812-9, (2016) (PubMed).
: "Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner." in: PLoS ONE, Vol. 10, Issue 5, pp. e0123340, (2015) (PubMed).
: "IL15RA drives antagonistic mechanisms of cancer development and immune control in lymphocyte-enriched triple-negative breast cancers." in: Cancer research, Vol. 74, Issue 17, pp. 4908-21, (2014) (PubMed).
: "CD8+ T cells are activated in an antigen-independent manner in HIV-infected individuals." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 192, Issue 4, pp. 1732-44, (2014) (PubMed).
: "Interleukin-15 enhances cellular proliferation and upregulates CNS homing molecules in pre-B acute lymphoblastic leukemia." in: Blood, Vol. 123, Issue 20, pp. 3116-27, (2014) (PubMed).
: "Qualitatively different T cell phenotypic responses to IL-2 versus IL-15 are unified by identical dependences on receptor signal strength and duration." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 192, Issue 1, pp. 123-35, (2013) (PubMed).
: "Phenotypic and functional characterization of NK cells in human immune response against the dimorphic fungus Paracoccidioides brasiliensis." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 189, Issue 2, pp. 935-45, (2012) (PubMed).
Aliases for IL-15 抗体
interleukin 15 (IL15) 抗体interleukin 15 (Il15) 抗体
AI503618 抗体
IL-15 抗体
IL15 抗体
您还需要查找其他产品吗？
You are here:
